Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of -0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-20.78 Million ≈ $-5.22 Million USD) by net assets (RM489.50 Million ≈ $122.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Pharmaniaga Bhd to measure how much of total assets are equity-financed.
Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Pharmaniaga Bhd to evaluate the quality of earnings relative to operating cash generation.
Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SFA Engineering Corporation
KQ:056190
|
0.010x |
|
Daesang Corp
KO:001680
|
0.093x |
|
Jiangxi Sunshine Dairy Co Ltd
SHE:001318
|
0.026x |
|
Zhejiang Kan Specialities Material Co Ltd
SHE:002012
|
-0.009x |
|
Hebei Gongda Keya Energy Technology Co. Ltd. A
SHE:301197
|
N/A |
|
Prisma Properties
ST:PRISMA
|
-0.087x |
|
Hollyland China Electronics Technology Corp Ltd
SHE:002729
|
0.036x |
|
Jiangsu Luokai Mechanical & Electrical Co Ltd Class A
SHG:603829
|
0.123x |
Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 7081 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | RM459.15 Million ≈ $115.28 Million |
RM-17.69 Million ≈ $-4.44 Million |
-0.039x | +86.82% |
| 2024-12-31 | RM-145.94 Million ≈ $-36.64 Million |
RM42.67 Million ≈ $10.71 Million |
-0.292x | -70.67% |
| 2023-12-31 | RM-274.09 Million ≈ $-68.81 Million |
RM46.95 Million ≈ $11.79 Million |
-0.171x | -141.92% |
| 2022-12-31 | RM-348.31 Million ≈ $-87.45 Million |
RM-142.34 Million ≈ $-35.74 Million |
0.409x | +400.12% |
| 2021-12-31 | RM470.44 Million ≈ $118.11 Million |
RM-64.06 Million ≈ $-16.08 Million |
-0.136x | -78.76% |
| 2020-12-31 | RM337.53 Million ≈ $84.74 Million |
RM-25.71 Million ≈ $-6.45 Million |
-0.076x | -113.56% |
| 2019-12-31 | RM337.85 Million ≈ $84.82 Million |
RM189.76 Million ≈ $47.64 Million |
0.562x | +449.59% |
| 2018-12-31 | RM509.34 Million ≈ $127.88 Million |
RM-81.83 Million ≈ $-20.55 Million |
-0.161x | -135.44% |
| 2017-12-31 | RM528.05 Million ≈ $132.57 Million |
RM239.41 Million ≈ $60.11 Million |
0.453x | +578.93% |
| 2016-12-31 | RM530.63 Million ≈ $133.22 Million |
RM35.44 Million ≈ $8.90 Million |
0.067x | +434.25% |
| 2015-12-31 | RM560.00 Million ≈ $140.60 Million |
RM7.00 Million ≈ $1.76 Million |
0.013x | -96.76% |
| 2014-12-31 | RM552.00 Million ≈ $138.59 Million |
RM213.00 Million ≈ $53.48 Million |
0.386x | -23.89% |
| 2013-12-31 | RM503.00 Million ≈ $126.29 Million |
RM255.00 Million ≈ $64.02 Million |
0.507x | +1355.27% |
| 2012-12-31 | RM488.00 Million ≈ $122.52 Million |
RM17.00 Million ≈ $4.27 Million |
0.035x | -- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more